Mechanism of Support
BIQSFP is managed through the Coordinating Center for Clinical Trials (CCCT) in the NCI Office of the Director (OD).
For FY 2012-2013, recipients of BIQSFP study funding will receive annual Administrative Supplements via the parent U10 Cooperative Agreement. The Administrative Supplements will be administered by CCCT in conjunction with the relevant NCI program (i.e., CCOP Research Base or Cooperative Group program).
For the FY 2012-2013 BIQSFP Announcement, the number of anticipated awards is contingent upon the availability of funds and the number of meritorious proposals submitted. NCI committed $10M to BIQSFP funding in FY 2011. Applicants may submit more than one trial concept with biomarker, imaging, quality of life studies or a CEA, provided they are scientifically distinct. However, both the scientific merit of the parent clinical trial concept and the merit of the biomarker, imaging, quality of life study, or CEA study must be approved by the appropriate review entity (SSC, CTEP or DCP) in order to be eligible for the BIQSFP funding.
